RecruitingNCT04327570

In-depth Immunological Investigation of COVID-19.

In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

100 participants

Start Date

Mar 27, 2020

Study Type

OBSERVATIONAL

Conditions

Coronavirus Infections

Summary

The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for directed medical interventions.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Patients \>/= 18 years old AND
Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease

Exclusion Criteria2

Age \< 18 years old
No informed consent

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient sampling

Blood draw, NP/rectal swab, bronchoscopy if clinically indicated, lung tissue if applicable

Locations(1)

UZ Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04327570

Related Trials

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

NCT0431836613 locations

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

NCT044295941 location